Resistance Mechanisms and Clinical Features of Fluconazole-Nonsusceptible Candida tropicalis Isolates Compared with Fluconazole-Less-Susceptible Isolates - Test2 - elhamkhani - TriplyDB

Resistance Mechanisms and Clinical Features of Fluconazole-Nonsusceptible Candida tropicalis Isolates Compared with Fluconazole-Less-Susceptible Isolates

Resistance Mechanisms and Clinical Features of Fluconazole-Nonsusceptible Candida tropicalis Isolates Compared with Fluconazole-Less-Susceptible Isolates

http://www.wikidata.org/entity/Q28833536

about

Antiproliferation of Berberine in Combination with Fluconazole from the Perspectives of Reactive Oxygen Species, Ergosterol and Drug Efflux in a Fluconazole-Resistant Candida tropicalis Isolate.Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species.From Lipid Homeostasis to Differentiation: Old and New Functions of the Zinc Cluster Proteins Ecm22, Upc2, Sut1 and Sut2.An Update on Candida tropicalis Based on Basic and Clinical Approaches Protein kinase A governs growth and virulence in Candida tropicalis.The Role of UPC2 Gene in Azole-Resistant Candida tropicalis.MDR1 overexpression combined with ERG11 mutations induce high-level fluconazole resistance in Candida tropicalis clinical isolates.Multilocus Sequence Typing (MLST) Genotypes of Bloodstream Isolates in Korea: Association With Antifungal Resistance, Mutations in Mismatch Repair Gene (Msh2), and Clinical Outcomes

P2860

Q37279005-3028352A-5ABC-4DDE-9AC2-C1A66C4F0703 Q37580801-1B9AF494-A675-4C7B-A9B7-141774F41AFF Q39221493-B1C74009-5693-44F7-9AE7-96F4F1B307FB Q42682766-F4EF488C-D755-47CA-8D3C-CC71C200C47A Q46237270-89AF9374-8744-4478-B845-3FC41C5A0896 Q51563685-18EC3DD0-2C13-41BB-AC5B-70565EF49148 Q52598225-5EAD0232-9CCC-4E04-8558-6E188E016BB6 Q57214733-90942054-F206-482A-8685-F8D2DCDF4B73

P2860

Resistance Mechanisms and Clinical Features of Fluconazole-Nonsusceptible Candida tropicalis Isolates Compared with Fluconazole-Less-Susceptible Isolates

http://www.wikidata.org/entity/Q28833536

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Resistance Mechanisms and Clin ...... zole-Less-Susceptible Isolates

@ast

Resistance Mechanisms and Clin ...... zole-Less-Susceptible Isolates

@en

type

label

Resistance Mechanisms and Clin ...... zole-Less-Susceptible Isolates

@ast

Resistance Mechanisms and Clin ...... zole-Less-Susceptible Isolates

@en

prefLabel

Resistance Mechanisms and Clin ...... zole-Less-Susceptible Isolates

@ast

Resistance Mechanisms and Clin ...... zole-Less-Susceptible Isolates

@en

P1433

Q28833536-D575DF49-81AA-4ABA-BCD2-F3290F83B30B

P1476

Q28833536-6F59E08E-193F-4085-9B86-C42DC74236CD

P2093

Q28833536-4A928375-8AF8-4901-A83D-67159C6F1E31

Q28833536-52754AFA-62BA-455A-A096-5D12606F6BA5

Q28833536-54DA40ED-8C91-4ABE-9A3D-4BB64E3AE001

Q28833536-5B6685A9-AF89-4DBA-93C4-C50F0D13909F

Q28833536-73C43F13-B78D-4683-B8E4-3EB5D6D4F631

Q28833536-83EC46E5-765D-4F07-A893-F21E190C41D1

Q28833536-A7FDEDE6-C878-4DD3-AA33-5822B78C078B

Q28833536-C174A75F-946C-4F3E-88CE-3A5C79D14D7A

Q28833536-C45C66B3-0EC9-4646-BA08-25F9417EE7E3

Q28833536-C85C28E6-AA5D-49E2-A090-2E7EC7D129BE

P2860

Q28833536-002EFAD3-00DF-4708-8ADA-61F12B19DD19

Q28833536-09521473-2839-43DE-A433-8BEB8998339D

Q28833536-0E0E8A3D-71A7-460F-A7AA-007F64B7B331

Q28833536-0FF69101-0C6B-4AEF-AD95-D30479A2F4B4

Q28833536-2AA8173F-E9E2-4B61-90F7-AFFBDB05143C

Q28833536-2C431010-2874-4A51-85AE-E2EFD29F01D6

Q28833536-36C44E39-CE42-4534-BCB0-8674206FB062

Q28833536-43AEB15E-99DD-48A7-95AB-A237FE568A50

Q28833536-471EF13B-9E26-4E7E-A331-55D17136CE67

Q28833536-56C72559-F8BF-46A2-B673-A15EB6C1DBF0

P304

Q28833536-249E6FDB-F1F1-4DAE-B5A5-857DAF9D2061

P31

Q28833536-E0761772-2C5F-43ED-8440-5D3BB6134D3C

P3181

Q28833536-239E45D9-0699-4AA5-BC24-A539B1BF7889

P356

Q28833536-CC16DDAD-AA85-49C4-932B-6C088F4479C9

P407

Q28833536-8BB0928A-98F7-490A-8AD9-2820ECCE8755

P433

Q28833536-C6F5375E-2F5E-4CE6-B2E8-0E633A8F95BB

P478

Q28833536-BD65B0CD-ED07-4DE7-9B38-8AF21CED0DD4

P577

Q28833536-254FC587-92ED-42A9-A2DE-A7B8B43F8CF4

P698

Q28833536-AAA2AB6D-0AC2-4D72-9B25-89072072D0D1

P921

Q28833536-B3A5CB39-E2D4-4FB2-A2B6-EC28567C15C9

P932

Q28833536-551B8EA5-2691-46EE-B3FD-270D1DC09A73

P3181

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Resistance Mechanisms and Clin ...... zole-Less-Susceptible Isolates

@en

P2093

Dong Wook Ryang

http://www.w3.org/2001/XMLSchema#string

Eun Jeong Won

http://www.w3.org/2001/XMLSchema#string

Jong Hee Shin

http://www.w3.org/2001/XMLSchema#string

Kyungwon Lee

http://www.w3.org/2001/XMLSchema#string

Mi-Na Kim

http://www.w3.org/2001/XMLSchema#string

Min Ji Choi

http://www.w3.org/2001/XMLSchema#string

Myung Geun Shin

http://www.w3.org/2001/XMLSchema#string

Soo Hyun Kim

http://www.w3.org/2001/XMLSchema#string

Soon Pal Suh

http://www.w3.org/2001/XMLSchema#string

Wee-Gyo Lee

http://www.w3.org/2001/XMLSchema#string

P2860

National surveillance of fungemia in Denmark (2004 to 2009)

An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans

Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods.

Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750

Multilocus sequence typing for differentiation of strains of Candida tropicalis.

Antifungal susceptibilities of bloodstream isolates of Candida species from nine hospitals in Korea: application of new antifungal breakpoints and relationship to antifungal usage.

Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.

Changes in karyotype and azole susceptibility of sequential bloodstream isolates from patients with Candida glabrata candidemia.

Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012

Gain-of-function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans.

P304

3653-61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3360307

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/AAC.02652-15

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27044550

http://www.w3.org/2001/XMLSchema#string

P921

infectious disease

P932

4879413

http://www.w3.org/2001/XMLSchema#string